Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China flag China · Delayed Price · Currency is CNY
61.62
+0.37 (0.60%)
At close: Dec 5, 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Company Description

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases.

The company was founded in 1970 and is headquartered in Lianyungang, China.

Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Country China
Founded 1970
Industry Drug Manufacturers - General
Sector Healthcare
Employees 20,238
CEO Ji Feng

Contact Details

Address:
No. 38, Huanghe Road
Lianyungang, Liaoning Province 222047
China
Phone 86 40 0828 3900
Website hengrui.com

Stock Details

Ticker Symbol 600276
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE0000014W7
SIC Code 2834

Key Executives

Name Position
Piao Yang Sun Executive Chairman of the Board
Hong Bin Dai Executive Deputy Chairman of the Board
Kin Chun Lau Chief Financial Officer
Jie Ping Sun Senior Vice President and Executive Director
Dr. Lian Shan Zhang Ph.D. Executive Vice President and Executive Director
Dr. Ningjun Jiang M.D., Ph.D. Executive Vice President, Chief Strategy Officer and Executive Director
Xiao Han Liu Board Secretary
Ya Ping Shen Deputy General Manager
Cheng Liao Deputy General Manager
Feng He Deputy General Manager